Form 144 Teladoc Health, Inc. Filed by: Rodrigues Fernando M.

Go back to Form 144 Teladoc Health, Inc. Filed by: Rodrigues Fernando M.

Truist Securities Reiterates Hold Rating on Teladoc (TDOC)

March 6, 2025 2:09 PM EST

Truist Securities analyst Jaliendra Singh reiterated a Hold rating and $10.00 price target on Teladoc (NYSE: TDOC)

The analyst comments "This morning, TDOC announced a pharmacy integration agreement with Gifthealth (private), a pharmacy partner for Eli Lilly's LillyDirect (LLY, Buy, Devarakonda). The partnership is expected to... More